TABLE 1.

Tumor B7-H3 QIF and its correlation with clinico-pathologic features and with lymphocyte subtypes

Characteristics	Cohort A			Cohort B			Cohort C
	B7-H3 (−)	B7-H3 (+)	p	B7-H3 (−)	B7-H3 (+)	p	B7-H3 (−)	B7-H3 (+)	p
Sex
Male	8	56	0.31	32	192	0.18	34	70	0.56
Female	11	43		2	36		35	86
Unknown				2	27
Age
<70y	11	59	1	30	173	0.18	43	88	0.46
≥70y	8	40		4	53		26	68
unknown				2	29
Stage
I–II	14	67	0.78	19	139	1	59	124	0.35
III–IV	5	32		13	90		10	32
unknown				4	26
Histology
ADC	15	67	0.03	17:	96	0.4	51	94	0.33
SCC	0	22		15	117		17	45
Other	4	10		0	16		1	17
Unknown				4	26
Smoker
current/former	15	94	0.03	24	192	0.05	47	129	0.02
Non Smoker	4	5		6	17		16	18
unknown				6	46		6	9
CD3
Low	10	48	0.8	21	124	0.29	32	81	0.47
High	9	51		15	131		37	75
CD8
Low	9	51	0.8	17	129	0.72	32	81	0.47
High	10	48		19	126		37	75
CD20
Low	8	50	0.61	22	124	0.21	40	73	0.14
High	11	49		14	132		29	83